Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

252 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Effectiveness and Safety of iGlarLixi (Insulin Glargine 100 U/mL Plus Lixisenatide) in Type 2 Diabetes According to the Timing of Daily Administration: Data from the REALI Pooled Analysis.
Haluzík M, Seufert J, Guja C, Bonnemaire M, Bigot G, Tournay M, Kis JT, Freemantle N. Haluzík M, et al. Among authors: seufert j. Diabetes Ther. 2023 Apr;14(4):639-652. doi: 10.1007/s13300-023-01375-8. Epub 2023 Feb 14. Diabetes Ther. 2023. PMID: 36787044 Free PMC article.
Continuous glucose monitoring for the routine care of type 2 diabetes mellitus.
Ajjan RA, Battelino T, Cos X, Del Prato S, Philips JC, Meyer L, Seufert J, Seidu S. Ajjan RA, et al. Among authors: seufert j. Nat Rev Endocrinol. 2024 Jul;20(7):426-440. doi: 10.1038/s41574-024-00973-1. Epub 2024 Apr 8. Nat Rev Endocrinol. 2024. PMID: 38589493 Free article. Review.
Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes.
Neal B, Perkovic V, Mahaffey KW, de Zeeuw D, Fulcher G, Erondu N, Shaw W, Law G, Desai M, Matthews DR; CANVAS Program Collaborative Group. Neal B, et al. N Engl J Med. 2017 Aug 17;377(7):644-657. doi: 10.1056/NEJMoa1611925. Epub 2017 Jun 12. N Engl J Med. 2017. PMID: 28605608 Free article. Clinical Trial.
Octreotide subcutaneous depot for acromegaly: A randomized, double-blind, placebo-controlled phase 3 trial, ACROINNOVA 1.
Ferone D, Freda P, Katznelson L, Gatto F, Kadioğlu P, Maffei P, Seufert J, Silverstein JM, Spencer-Segal JL, Isaeva E, Dreval A, Harrie M, Svedberg A, Tiberg F. Ferone D, et al. Among authors: seufert j. J Clin Endocrinol Metab. 2024 Oct 8:dgae707. doi: 10.1210/clinem/dgae707. Online ahead of print. J Clin Endocrinol Metab. 2024. PMID: 39378125
Comparison of Pheochromocytoma-Specific Morbidity and Mortality Among Adults With Bilateral Pheochromocytomas Undergoing Total Adrenalectomy vs Cortical-Sparing Adrenalectomy.
Neumann HPH, Tsoy U, Bancos I, Amodru V, Walz MK, Tirosh A, Kaur RJ, McKenzie T, Qi X, Bandgar T, Petrov R, Yukina MY, Roslyakova A, van der Horst-Schrivers ANA, Berends AMA, Hoff AO, Castroneves LA, Ferrara AM, Rizzati S, Mian C, Dvorakova S, Hasse-Lazar K, Kvachenyuk A, Peczkowska M, Loli P, Erenler F, Krauss T, Almeida MQ, Liu L, Zhu F, Recasens M, Wohllk N, Corssmit EPM, Shafigullina Z, Calissendorff J, Grozinsky-Glasberg S, Kunavisarut T, Schalin-Jäntti C, Castinetti F, Vlcek P, Beltsevich D, Egorov VI, Schiavi F, Links TP, Lechan RM, Bausch B, Young WF Jr, Eng C; International Bilateral-Pheochromocytoma-Registry Group. Neumann HPH, et al. JAMA Netw Open. 2019 Aug 2;2(8):e198898. doi: 10.1001/jamanetworkopen.2019.8898. JAMA Netw Open. 2019. PMID: 31397861 Free PMC article.
Effectiveness of add-on therapy with SGLT2 inhibitors or GLP-1 receptor agonists in adults with type 1 diabetes: A prospective DPV registry study.
Baechle C, Rosenbauer J, Stahl-Pehe A, Seufert J, Mader JK, Wagner C, Wosch FJ, Erath D, Holl RW, Lanzinger S; in cooperation with the DPV‐Science initiative, supported by the German Center for Diabetes Research (DZD). Baechle C, et al. Among authors: seufert j. Diabetes Obes Metab. 2024 Dec 27. doi: 10.1111/dom.16149. Online ahead of print. Diabetes Obes Metab. 2024. PMID: 39727159 No abstract available.
Regional socioeconomic deprivation associated with the use of sodium-glucose cotransporter-2 inhibitors and glucagon-like peptide-1 receptor agonists in adults with type 2 diabetes in Germany.
Auzanneau M, Seufert J, Zimny S, Haak T, Zeyfang A, Gölz S, Hugenberg I, Pavel M, Rosenbauer J, Holl RW. Auzanneau M, et al. Among authors: seufert j. Diabetes Obes Metab. 2024 Sep;26(9):4116-4120. doi: 10.1111/dom.15741. Epub 2024 Jul 9. Diabetes Obes Metab. 2024. PMID: 38982585 No abstract available.
252 results